Publications by Researcher: Zannettino, ACW

2012 Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?
Noll, JE Williams, SA Purton, LE Zannettino, ACW
2013 EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repair
Arthur, A Panagopoulos, RA Cooper, L Menicanin, D Parkinson, IH Codrington, JD Vandyke, K Zannettino, ACW Koblar, SA Sims, NA Matsuo, K Gronthos, S
2013 Prospective Histomorphometric and DXA Evaluation of Bone Remodeling in Imatinib-Treated CML Patients: Evidence for Site-Specific Skeletal Effects
Vandyke, K Fitter, S Drew, J Fukumoto, S Schultz, CG Sims, NA Yeung, DT Hughes, TP Zannettino, ACW
2014 Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells
Noll, JE Williams, SA Tong, CM Wang, HS Quach, JM Purton, LE Pilkington, K To, LB Evdokiou, A Gronthos, S Zannettino, ACW
2015 EphB4 Expressing Stromal Cells Exhibit an Enhanced Capacity for Hematopoietic Stem Cell Maintenance
Nguyen, TM Arthur, A Panagopoulos, R Paton, S Hayball, JD Zannettino, ACW Purton, LE Matsuo, K Gronthos, S
2015 BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells
Baker, EK Taylor, S Gupte, A Sharp, PP Walia, M Walsh, NC Zannettino, ACW Chalk, AM Burns, CJ Walkley, CR
2015 Brief Report: The Differential Roles of mTORC1 and mTORC2 in Mesenchymal Stem Cell Differentiation
Martin, SK Fitter, S Dutta, AK Matthews, MP Walkley, CR Hall, MN Ruegg, MA Gronthos, S Zannettino, ACW
2015 Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma
Gupte, A Baker, EK Wan, SS Stewart, E Loh, A Shelat, AA Gould, CM Chalk, AM Taylor, S Lackovic, K Karlstrom, A Mutsaers, AJ Desai, J Madhamshettiwar, PB Zannettino, ACW Burns, C Huang, DCS Dyer, MA Simpson, KJ Walkley, CR